Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial
Standard
Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial. / Krisai, Philipp; Blum, Steffen; Schnabel, Renate B; Sticherling, Christian; Kühne, Michael; von Felten, Stefanie; Ammann, Peter; Pruvot, Etienne; Albert, Christine M; Conen, David.
In: CIRC-ARRHYTHMIA ELEC, Vol. 13, No. 7, e008197, 07.2020.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial
AU - Krisai, Philipp
AU - Blum, Steffen
AU - Schnabel, Renate B
AU - Sticherling, Christian
AU - Kühne, Michael
AU - von Felten, Stefanie
AU - Ammann, Peter
AU - Pruvot, Etienne
AU - Albert, Christine M
AU - Conen, David
PY - 2020/7
Y1 - 2020/7
KW - Anti-Inflammatory Agents/adverse effects
KW - Antibodies, Monoclonal, Humanized/adverse effects
KW - Atrial Fibrillation/diagnosis
KW - Double-Blind Method
KW - Electric Countershock/adverse effects
KW - Female
KW - Heart Rate/drug effects
KW - Humans
KW - Male
KW - Pilot Projects
KW - Recurrence
KW - Risk Factors
KW - Time Factors
KW - Treatment Outcome
U2 - 10.1161/CIRCEP.119.008197
DO - 10.1161/CIRCEP.119.008197
M3 - Other (editorial matter etc.)
C2 - 32536195
VL - 13
JO - CIRC-ARRHYTHMIA ELEC
JF - CIRC-ARRHYTHMIA ELEC
SN - 1941-3149
IS - 7
M1 - e008197
ER -